,61,62,63 Our findings indicated a pronounced correlation between increased NMUR1 levels in CD8+ T cells and enhanced immunotherapy outcomes, suggesting that NMU-NMUR1 signaling could potentially alter CD8+ T cell metabolism in the CRC microenvironment. The gene discussed is CD8A; the disease is colorectal carcinoma.